Zhangzhou Pientzehuang Pharmaceutical., Ltd (SHA:600436)
China · Delayed Price · Currency is CNY 141.18
-0.01 (-0.01%)
May 8, 2026, 3:00 PM CST
SHA:600436 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 1,902 | 2,159 | 2,977 | 2,797 | 2,472 | 2,432 |
Depreciation & Amortization | 120.59 | 120.59 | 94.6 | 102.38 | 80.36 | 133.49 |
Other Amortization | 8.51 | 8.51 | 9.91 | 26.31 | 15.34 | 15.96 |
Loss (Gain) From Sale of Assets | -3.41 | -3.41 | -4.66 | -1.5 | -11.48 | -28.91 |
Asset Writedown & Restructuring Costs | -0.39 | -0.39 | 0.79 | 0.54 | 1.8 | 2.34 |
Loss (Gain) From Sale of Investments | -343.76 | -343.76 | -136.79 | -134.51 | -75.19 | -23.35 |
Provision & Write-off of Bad Debts | 28.91 | 28.91 | 2.94 | 12.27 | -6.78 | 7.1 |
Other Operating Activities | 649.81 | 19.48 | 60.21 | 89.36 | 123.88 | 100.42 |
Change in Accounts Receivable | -50.42 | -50.42 | 272.9 | -181.92 | 4,258 | -2,089 |
Change in Inventory | -1,721 | -1,721 | -1,600 | -758.78 | -199.39 | -261.56 |
Change in Accounts Payable | -222.55 | -222.55 | -363.45 | 306.43 | 205.02 | 232.58 |
Operating Cash Flow | 451.06 | 77.03 | 1,314 | 2,207 | 6,873 | 462.27 |
Operating Cash Flow Growth | -73.44% | -94.14% | -40.47% | -67.89% | 1386.79% | -68.49% |
Capital Expenditures | -390.77 | -339.8 | -1,068 | -141.87 | -175.37 | -92.17 |
Sale of Property, Plant & Equipment | 1.14 | 3.44 | 4.13 | 1.25 | 13.74 | 5.31 |
Investment in Securities | 2,147 | 2,047 | 2,354 | -2,658 | -6,170 | 143.32 |
Other Investing Activities | 352.92 | 27.12 | 34.52 | 24.12 | 27.03 | 21.82 |
Investing Cash Flow | 2,110 | 1,738 | 1,324 | -2,774 | -6,305 | 78.29 |
Short-Term Debt Issued | - | - | - | - | - | 1,410 |
Long-Term Debt Issued | - | 910.34 | 1,161 | 1,198 | 1,593 | - |
Total Debt Issued | 864.19 | 910.34 | 1,161 | 1,198 | 1,593 | 1,410 |
Short-Term Debt Repaid | - | - | - | - | - | -1,356 |
Long-Term Debt Repaid | - | -1,018 | -1,272 | -1,180 | -1,429 | -31.79 |
Total Debt Repaid | -925.2 | -1,018 | -1,272 | -1,180 | -1,429 | -1,387 |
Net Debt Issued (Repaid) | -61.01 | -107.32 | -111.2 | 17.85 | 164.12 | 23.09 |
Common Dividends Paid | -1,966 | -1,968 | -2,127 | -784.64 | -760.63 | -569.21 |
Other Financing Activities | 9.09 | 0.34 | -2.08 | -2.51 | 20.69 | 5.9 |
Financing Cash Flow | -2,018 | -2,075 | -2,241 | -769.3 | -575.82 | -540.23 |
Foreign Exchange Rate Adjustments | -7.42 | -2.26 | 8.16 | 2.43 | 11.44 | -4.62 |
Net Cash Flow | 536.27 | -261.67 | 405.7 | -1,334 | 3.84 | -4.29 |
Free Cash Flow | 60.28 | -262.77 | 245.41 | 2,065 | 6,698 | 370.11 |
Free Cash Flow Growth | -89.25% | - | -88.11% | -69.17% | 1709.66% | -64.69% |
Free Cash Flow Margin | 0.70% | -2.92% | 2.27% | 20.53% | 77.04% | 4.61% |
Free Cash Flow Per Share | 0.10 | -0.44 | 0.41 | 3.42 | 11.11 | 0.61 |
Cash Income Tax Paid | 705.7 | 771.85 | 1,167 | 1,155 | 989.67 | 969.09 |
Levered Free Cash Flow | 2,152 | -848.65 | -665.12 | 1,411 | 1,370 | 1,610 |
Unlevered Free Cash Flow | 2,172 | -828.81 | -641.61 | 1,434 | 1,394 | 1,631 |
Change in Working Capital | -1,912 | -1,912 | -1,690 | -685.58 | 4,273 | -2,177 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.